What Will It Take To End The COVID-19 Pandemic?

The [vaccine] innovators hold patent rights and trade secret rights over those technologies, and they’re unwilling to share them broadly to other manufacturers. So we have artificially constricted supply, Professor Brook Baker tells NPR.